SHH-MBs are characterized by the activation of the SHH pathway with the most commonly affected genes being PTCH1, SUFU, SMO, GLI1, GLI2 and MYCN (6) as well as mutations in the TERT promoter (7), TP53 and PTEN (8). The gene discussed is MYCN; the disease is Mobius syndrome.